Monthly Archives: March 2021

You can now apply for a government loan to finance your LPC

Just six weeks after two second years at ULaw, a petition has been launched asking for this. The University of Law (ULaw) has launched a first-of-its-kind government-backed student loan to help future lawyers pay the insane costs of professional legal education. Prospective Legal Practice Course (LPC) students studying the rigorous …

Read More »

Global Loan Creation & Maintenance Software Market Sales, Revenue, Facts & Figures, Analysis, Forecast to 2027 Ellie Mae, Calyx Software, FICS, Fiserv

Global Training and Loan Management Software Market The 2021-27 report explains the important details demanded by customers in terms of industrial advantages or disadvantages and the futuristic scope of the industry. The research report presents all the necessary data of Loan Creation and Maintenance Software industry competitors, growth rate, revenue, …

Read More »

Update: Overview of loaned players

As we all wait for FC Cincinnati to resume play with the #HellIsReal Derby at 10:30 p.m. on July 11, there’s a good chance some FCC players have already played earlier today. The USL Championship returns to play that day, meaning three FCC players could feature for the first time …

Read More »

First look at the PPP loan forgiveness request

On May 15, the Small Business Administration (SBA) released the much anticipated Payroll Protection Program Forgiveness Request. Under the Payroll Protection Program (P3), entrepreneurs can request cancellation of up to 100% of their loan. However, the SBA did not give clear guidance on the details of the loan cancellation, which …

Read More »

Dicerna Announces FDA Acceptance of Lilly’s Investigational New Drug Application (IND) for First RNAi Candidate GalXC ™ Under the Companies’ Global Research Collaboration and Licensing Agreement

– Milestone achievement reflects first experimental candidate to emerge as part of multi-target collaboration and triggers $ 10 million payment to Dicerna – – Lilly aims to launch phase 1 clinical trial of LY3561774 by the end of 2020 – Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), (the “Company” or “Dicerna”), a …

Read More »